HB 1309 adds new rules to Pennsylvania's Human Services Code for electronic monitoring in homes where in-home supportive care is provided under the LIFE program. It requires care recipients or their guardians to notify caregivers in writing about any video-only monitoring device before care begins, including its location and function, while prohibiting audio recording or placement in bathrooms. The bill mandates that devices be visible, timestamp recordings, and allows caregivers to consent to visual monitoring, with costs borne by the care recipient or guardian. It also prohibits denying care or retaliating against individuals who use such devices, ensuring privacy protections for care recipients.
HB 1088 amends Pennsylvania's 1921 Insurance Company Law to require casualty insurance policies to cover blood pressure monitors. This directly affects policyholders who rely on these devices for managing health conditions like hypertension, ensuring they are not excluded from standard coverage. The bill adds a specific provision mandating insurers to include blood pressure monitors as covered items under casualty insurance policies. It changes insurer obligations without altering broader policy terms, focusing on making a common medical device accessible through existing insurance frameworks.
This resolution (SR 24) urges the U.S. Congress to pass two specific laws: a food labeling modernization act and an allergen disclosure law for medications. It seeks to require clearer front-of-package labels on food showing gluten sources (including barley, oats, and rye, not just wheat) and to mandate that medication labels identify ingredients derived from major food allergens like gluten. The resolution directly addresses people with celiac disease or gluten intolerance - impacting an estimated 7% of the U.S. population - who face serious health risks from unlabeled gluten exposure. Current federal labeling only requires wheat identification, leaving other gluten sources unmarked and putting sensitive consumers at risk. As a non-binding resolution, it does not create new law but calls on Congress to act.
SB 571 authorizes Pennsylvania to join the Interstate Occupational Therapy Licensure Compact, enabling occupational therapists licensed in one participating state to practice in Pennsylvania without obtaining a separate Pennsylvania license. It establishes that therapists practice where their patient is located, requires states to share licensure and disciplinary information, and includes provisions for military spouses relocating across state lines. The bill directly affects licensed occupational therapists, patients seeking services across state lines, and state licensing boards managing professional standards. Key mechanisms include mutual license recognition, a shared data system for tracking disciplinary actions, and telehealth service access rules. (3 sentences)
SB 582 streamlines grant applications for Pennsylvania fire and emergency medical services (EMS) companies. It sets a 45-day annual application window, requires the state to act on applications within 60 days (with unaddressed applications deemed approved), and allows one 15-day extension per company every three years for reporting without needing to prove hardship. The bill directly affects local fire and EMS companies seeking state funding under Title 35. This procedural update simplifies administrative processes but does not change grant eligibility, amounts, or funding levels.
Tags
Public Safety
HB 839 amends Pennsylvania's 1921 Insurance Company Law to ensure patients can continue care with their current healthcare providers during network changes. It requires insurers to provide a 120-day transitional period (up from 60 days) for patients if a provider leaves a network or a contract expires, with extensions possible for clinical needs - especially for pregnancy-related care through postpartum. Insurers must notify patients of network changes and cannot allow non-participating providers to bill patients directly during this period, covering services at the same terms as in-network providers. The law applies to new or renewed health insurance policies 180 days after enactment and takes effect 60 days after passage.
HB 1346 amends Pennsylvania's Insurance Company Law to mandate coverage for menopause treatments in health insurance policies. This bill requires health insurance policies offered or renewed in the Commonwealth to provide coverage for both hormonal and non-hormonal treatments for menopausal symptoms. The required coverage includes FDA-approved drugs, devices, behavioral therapy, and treatments for menopause induced by a hysterectomy. This ensures individuals in Pennsylvania experiencing menopause or related symptoms have access to covered treatments, subject to the standard terms and conditions of their health insurance policy.
HB 1244 requires health insurance policies and government health programs in Pennsylvania to cover pelvic floor therapy and related treatments for pelvic floor dysfunction. This includes services like biofeedback, trigger point therapy, electrical stimulation, and postoperative care for prostatectomies, hysterectomies, and postpartum assessments. The coverage applies to policies issued or renewed after the bill's effective date, though insurers may still apply medical necessity standards and cost-sharing requirements. The bill directly affects all health insurance companies and government health programs (such as Medicaid) operating under Pennsylvania's insurance law.
HB 432 establishes Pennsylvania's Maternal Care Access Program under the Department of Health to address gaps in maternal healthcare. The bill identifies counties as "maternal care access zones" using the Maternal Vulnerability Index (based on social factors like poverty, education, and healthcare access) and the Social Vulnerability Index. It requires the Department to develop regulations for improving access to obstetric care, birth centers, and providers in areas classified as "maternity care deserts" (regions lacking hospitals, birth centers, or specialized providers within 25 miles). The program directly affects underserved communities and the Department of Health, focusing on concrete policy changes to expand maternal health resources.
HB 1470 proposes to amend the Human Services Code to establish a subscription-like model for GLP-1 agonists used to treat obesity within public assistance programs. The bill directs the state department to seek a waiver from the Centers for Medicare and Medicaid Services (CMS) to allow the Commonwealth to enter into value-based arrangements with drug manufacturers. These arrangements are defined as "supplemental rebate agreements," where the Commonwealth pays an agreed amount per treatment up to a cap, after which additional treatments are provided at no cost. If federal approval is granted, the department would then develop regulations to implement this new payment system.
